Search Icon
Home
Resources
Press Releases

Press Releases

  • Press Releases

AAM Applauds Senate Bill to Protect Patient Access to Affordable Medicines
  • Press Releases

AAM Comments on End of Year Funding Bill
  • Press Releases

Medicare Plans Continue Trend of Restricting Generic Drugs
  • Press Releases

AAM & Biosimilars Council Statement on Presidential Election
  • Press Releases

$2 Generics List Not the Solution
  • Press Releases

John Murphy Named President and CEO of AAM
  • Press Releases

40 Years of Hatch-Waxman – Trillions in Savings for Patients
  • Press Releases

AAM Urges Congress to Pass Key Bills Considered by the Senate HELP Committee This Week
  • Press Releases

Generic Medicines Increase Patient Access More Than Government Negotiated Price Controls
  • Press Releases

Statement Regarding Senate Judiciary Committee Markup of the PREVAIL Act and the PERA Act
  • Press Releases

AAM and the Biosimilar Council Host Patent Abuse Congressional Briefing: What’s Truly Preventing Low-Cost Medicines from Getting to Patients: A Look at the Broken Patent System
  • Press Releases

Generic and Biosimilar Medicines Save $445 Billion in 2023
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe
© 2024 Association for Accessible Medicines (AAM), All Rights Reserved Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram